Viewing Study NCT05959811



Ignite Creation Date: 2024-05-06 @ 7:16 PM
Last Modification Date: 2024-10-26 @ 3:04 PM
Study NCT ID: NCT05959811
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-07-27
First Post: 2023-06-20

Brief Title: Meridian Yoga on Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients
Sponsor: China Medical University Hospital
Organization: China Medical University Hospital

Study Overview

Official Title: Meridian Yoga on Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients
Status: NOT_YET_RECRUITING
Status Verified Date: 2023-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CIPN
Brief Summary: Chemotherapy-induced peripheral neuropathy CIPN is a common side effect in breast cancer patients with completion of chemotherapy and that is characterized by associated clinical symptoms such as pain tingling numbness and paresthesia etc CIPN also interferes with patients functions of daily living and leads to chronic functional decline and a reduced quality of life Meridian yoga is beneficial to the treatment of patients with peripheral neuropathy and the improvement of their quality of life
Detailed Description: Chemotherapy-induced peripheral neuropathy CIPN is a common side effect in breast cancer patients with completion of chemotherapy and that is characterized by associated clinical symptoms such as pain tingling numbness and paresthesia etc CIPN also interferes with patients functions of daily living and leads to chronic functional decline and a reduced quality of life Meridian yoga is beneficial to the treatment of patients with peripheral neuropathy and the improvement of their quality of life

Therefore the aim of this study was to evaluate the efficacy of meridian yoga for CIPN in breast cancer patients The investigators designed a clinical randomized controlled trial in which 80 patients with CIPN were equally divided into a control group 8 weeks of general care and a treatment group general care plus 16 times yoga interventions for 8 weeks The assessment time was before vision 1 and at the completion of 8 weeks of Meridian yoga treatment vision 2 The primary outcome was the change in scores of the neuropathic pain scale Chinese version The secondary outcome was to the changes of meridian energy Meridian Energy Analyzer MEAD Perfusion Index PI value of peripheral blood flow and the changes of cortisol and IL-6 level in salivary fluid

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None